Researchers have discovered a mechanism of centromere inactivation in human cells that occurs during the aging process.
The decline in the levels of the histone H3 variant CENP-A and centromeric proteins CENP-C in aging cells is attributed to p53 activation, leading to the inactivation of centromeres.
The recruitment of lysine-specific demethylase 1 (LSD1) to centromeres in aged cells plays a role in transcriptional repression, and inhibiting LSD1 restores centromeric function.
Dual inhibition of p53 and LSD1 not only restores centromeric function but also improves the cell cycle potential and genome stability in aging cells.